Abstract
Summary
Fenbendazole is a drug substance classified under the category ‘Anthelmintic Agent’ (for veterinary use) .It is used in the treatment & control of fluke infections of the digestive system caused by roundworms , tapeworms , hookworms , lungworms which are generally found in Cats , Sheeps, Goats ,Pet birds , Pigeons. Hence this drug is an effective de-wormer in animals.
LPI (LP Information)' newest research report, the “Anthelmintic Fenbendazole Industry Forecast” looks at past sales and reviews total world Anthelmintic Fenbendazole sales in 2022, providing a comprehensive analysis by region and market sector of projected Anthelmintic Fenbendazole sales for 2023 through 2029. With Anthelmintic Fenbendazole sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anthelmintic Fenbendazole industry.
This Insight Report provides a comprehensive analysis of the global Anthelmintic Fenbendazole landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anthelmintic Fenbendazole portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Anthelmintic Fenbendazole market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anthelmintic Fenbendazole and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anthelmintic Fenbendazole.
The global Anthelmintic Fenbendazole market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Anthelmintic Fenbendazole is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Anthelmintic Fenbendazole is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Anthelmintic Fenbendazole is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Anthelmintic Fenbendazole players cover Alivira Animal Health, Vaishali Pharma, Bazayan & Co, Rochem International, Jiangsu Baozong & Baoda Pharmachem, Shanxi Hanjiang pharmaceutical, Lasa Supergenerics Limited and Procyon Life Sciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Anthelmintic Fenbendazole market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
≥98%
≥99%
Other
Segmentation by application
Fenbendazole Granule
Fenbendazole Powder
Fenbenazole Tablet
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Alivira Animal Health
Vaishali Pharma
Bazayan & Co
Rochem International
Jiangsu Baozong & Baoda Pharmachem
Shanxi Hanjiang pharmaceutical
Lasa Supergenerics Limited
Procyon Life Sciences
Key Questions Addressed in this Report
What is the 10-year outlook for the global Anthelmintic Fenbendazole market?
What factors are driving Anthelmintic Fenbendazole market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anthelmintic Fenbendazole market opportunities vary by end market size?
How does Anthelmintic Fenbendazole break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Anthelmintic Fenbendazole Industry Forecast” looks at past sales and reviews total world Anthelmintic Fenbendazole sales in 2022, providing a comprehensive analysis by region and market sector of projected Anthelmintic Fenbendazole sales for 2023 through 2029. With Anthelmintic Fenbendazole sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anthelmintic Fenbendazole industry.
This Insight Report provides a comprehensive analysis of the global Anthelmintic Fenbendazole landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anthelmintic Fenbendazole portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Anthelmintic Fenbendazole market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anthelmintic Fenbendazole and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anthelmintic Fenbendazole.
The global Anthelmintic Fenbendazole market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Anthelmintic Fenbendazole is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Anthelmintic Fenbendazole is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Anthelmintic Fenbendazole is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Anthelmintic Fenbendazole players cover Alivira Animal Health, Vaishali Pharma, Bazayan & Co, Rochem International, Jiangsu Baozong & Baoda Pharmachem, Shanxi Hanjiang pharmaceutical, Lasa Supergenerics Limited and Procyon Life Sciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Anthelmintic Fenbendazole market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
≥98%
≥99%
Other
Segmentation by application
Fenbendazole Granule
Fenbendazole Powder
Fenbenazole Tablet
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Alivira Animal Health
Vaishali Pharma
Bazayan & Co
Rochem International
Jiangsu Baozong & Baoda Pharmachem
Shanxi Hanjiang pharmaceutical
Lasa Supergenerics Limited
Procyon Life Sciences
Key Questions Addressed in this Report
What is the 10-year outlook for the global Anthelmintic Fenbendazole market?
What factors are driving Anthelmintic Fenbendazole market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anthelmintic Fenbendazole market opportunities vary by end market size?
How does Anthelmintic Fenbendazole break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anthelmintic Fenbendazole Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Anthelmintic Fenbendazole by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Anthelmintic Fenbendazole by Country/Region, 2018, 2022 & 2029
2.2 Anthelmintic Fenbendazole Segment by Type
2.2.1 ≥98%
2.2.2 ≥99%
2.2.3 Other
2.3 Anthelmintic Fenbendazole Sales by Type
2.3.1 Global Anthelmintic Fenbendazole Sales Market Share by Type (2018-2023)
2.3.2 Global Anthelmintic Fenbendazole Revenue and Market Share by Type (2018-2023)
2.3.3 Global Anthelmintic Fenbendazole Sale Price by Type (2018-2023)
2.4 Anthelmintic Fenbendazole Segment by Application
2.4.1 Fenbendazole Granule
2.4.2 Fenbendazole Powder
2.4.3 Fenbenazole Tablet
2.4.4 Other
2.5 Anthelmintic Fenbendazole Sales by Application
2.5.1 Global Anthelmintic Fenbendazole Sale Market Share by Application (2018-2023)
2.5.2 Global Anthelmintic Fenbendazole Revenue and Market Share by Application (2018-2023)
2.5.3 Global Anthelmintic Fenbendazole Sale Price by Application (2018-2023)
3 Global Anthelmintic Fenbendazole by Company
3.1 Global Anthelmintic Fenbendazole Breakdown Data by Company
3.1.1 Global Anthelmintic Fenbendazole Annual Sales by Company (2018-2023)
3.1.2 Global Anthelmintic Fenbendazole Sales Market Share by Company (2018-2023)
3.2 Global Anthelmintic Fenbendazole Annual Revenue by Company (2018-2023)
3.2.1 Global Anthelmintic Fenbendazole Revenue by Company (2018-2023)
3.2.2 Global Anthelmintic Fenbendazole Revenue Market Share by Company (2018-2023)
3.3 Global Anthelmintic Fenbendazole Sale Price by Company
3.4 Key Manufacturers Anthelmintic Fenbendazole Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anthelmintic Fenbendazole Product Location Distribution
3.4.2 Players Anthelmintic Fenbendazole Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Anthelmintic Fenbendazole by Geographic Region
4.1 World Historic Anthelmintic Fenbendazole Market Size by Geographic Region (2018-2023)
4.1.1 Global Anthelmintic Fenbendazole Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Anthelmintic Fenbendazole Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Anthelmintic Fenbendazole Market Size by Country/Region (2018-2023)
4.2.1 Global Anthelmintic Fenbendazole Annual Sales by Country/Region (2018-2023)
4.2.2 Global Anthelmintic Fenbendazole Annual Revenue by Country/Region (2018-2023)
4.3 Americas Anthelmintic Fenbendazole Sales Growth
4.4 APAC Anthelmintic Fenbendazole Sales Growth
4.5 Europe Anthelmintic Fenbendazole Sales Growth
4.6 Middle East & Africa Anthelmintic Fenbendazole Sales Growth
5 Americas
5.1 Americas Anthelmintic Fenbendazole Sales by Country
5.1.1 Americas Anthelmintic Fenbendazole Sales by Country (2018-2023)
5.1.2 Americas Anthelmintic Fenbendazole Revenue by Country (2018-2023)
5.2 Americas Anthelmintic Fenbendazole Sales by Type
5.3 Americas Anthelmintic Fenbendazole Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anthelmintic Fenbendazole Sales by Region
6.1.1 APAC Anthelmintic Fenbendazole Sales by Region (2018-2023)
6.1.2 APAC Anthelmintic Fenbendazole Revenue by Region (2018-2023)
6.2 APAC Anthelmintic Fenbendazole Sales by Type
6.3 APAC Anthelmintic Fenbendazole Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Anthelmintic Fenbendazole by Country
7.1.1 Europe Anthelmintic Fenbendazole Sales by Country (2018-2023)
7.1.2 Europe Anthelmintic Fenbendazole Revenue by Country (2018-2023)
7.2 Europe Anthelmintic Fenbendazole Sales by Type
7.3 Europe Anthelmintic Fenbendazole Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Anthelmintic Fenbendazole by Country
8.1.1 Middle East & Africa Anthelmintic Fenbendazole Sales by Country (2018-2023)
8.1.2 Middle East & Africa Anthelmintic Fenbendazole Revenue by Country (2018-2023)
8.2 Middle East & Africa Anthelmintic Fenbendazole Sales by Type
8.3 Middle East & Africa Anthelmintic Fenbendazole Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anthelmintic Fenbendazole
10.3 Manufacturing Process Analysis of Anthelmintic Fenbendazole
10.4 Industry Chain Structure of Anthelmintic Fenbendazole
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anthelmintic Fenbendazole Distributors
11.3 Anthelmintic Fenbendazole Customer
12 World Forecast Review for Anthelmintic Fenbendazole by Geographic Region
12.1 Global Anthelmintic Fenbendazole Market Size Forecast by Region
12.1.1 Global Anthelmintic Fenbendazole Forecast by Region (2024-2029)
12.1.2 Global Anthelmintic Fenbendazole Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Anthelmintic Fenbendazole Forecast by Type
12.7 Global Anthelmintic Fenbendazole Forecast by Application
13 Key Players Analysis
13.1 Alivira Animal Health
13.1.1 Alivira Animal Health Company Information
13.1.2 Alivira Animal Health Anthelmintic Fenbendazole Product Portfolios and Specifications
13.1.3 Alivira Animal Health Anthelmintic Fenbendazole Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Alivira Animal Health Main Business Overview
13.1.5 Alivira Animal Health Latest Developments
13.2 Vaishali Pharma
13.2.1 Vaishali Pharma Company Information
13.2.2 Vaishali Pharma Anthelmintic Fenbendazole Product Portfolios and Specifications
13.2.3 Vaishali Pharma Anthelmintic Fenbendazole Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Vaishali Pharma Main Business Overview
13.2.5 Vaishali Pharma Latest Developments
13.3 Bazayan & Co
13.3.1 Bazayan & Co Company Information
13.3.2 Bazayan & Co Anthelmintic Fenbendazole Product Portfolios and Specifications
13.3.3 Bazayan & Co Anthelmintic Fenbendazole Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Bazayan & Co Main Business Overview
13.3.5 Bazayan & Co Latest Developments
13.4 Rochem International
13.4.1 Rochem International Company Information
13.4.2 Rochem International Anthelmintic Fenbendazole Product Portfolios and Specifications
13.4.3 Rochem International Anthelmintic Fenbendazole Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Rochem International Main Business Overview
13.4.5 Rochem International Latest Developments
13.5 Jiangsu Baozong & Baoda Pharmachem
13.5.1 Jiangsu Baozong & Baoda Pharmachem Company Information
13.5.2 Jiangsu Baozong & Baoda Pharmachem Anthelmintic Fenbendazole Product Portfolios and Specifications
13.5.3 Jiangsu Baozong & Baoda Pharmachem Anthelmintic Fenbendazole Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Jiangsu Baozong & Baoda Pharmachem Main Business Overview
13.5.5 Jiangsu Baozong & Baoda Pharmachem Latest Developments
13.6 Shanxi Hanjiang pharmaceutical
13.6.1 Shanxi Hanjiang pharmaceutical Company Information
13.6.2 Shanxi Hanjiang pharmaceutical Anthelmintic Fenbendazole Product Portfolios and Specifications
13.6.3 Shanxi Hanjiang pharmaceutical Anthelmintic Fenbendazole Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Shanxi Hanjiang pharmaceutical Main Business Overview
13.6.5 Shanxi Hanjiang pharmaceutical Latest Developments
13.7 Lasa Supergenerics Limited
13.7.1 Lasa Supergenerics Limited Company Information
13.7.2 Lasa Supergenerics Limited Anthelmintic Fenbendazole Product Portfolios and Specifications
13.7.3 Lasa Supergenerics Limited Anthelmintic Fenbendazole Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Lasa Supergenerics Limited Main Business Overview
13.7.5 Lasa Supergenerics Limited Latest Developments
13.8 Procyon Life Sciences
13.8.1 Procyon Life Sciences Company Information
13.8.2 Procyon Life Sciences Anthelmintic Fenbendazole Product Portfolios and Specifications
13.8.3 Procyon Life Sciences Anthelmintic Fenbendazole Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Procyon Life Sciences Main Business Overview
13.8.5 Procyon Life Sciences Latest Developments
14 Research Findings and Conclusion